180 related articles for article (PubMed ID: 19589137)
1. The role of VEGF-C/D and Flt-4 in the lymphatic metastasis of early-stage invasive cervical carcinoma.
Yu H; Zhang S; Zhang R; Zhang L
J Exp Clin Cancer Res; 2009 Jul; 28(1):98. PubMed ID: 19589137
[TBL] [Abstract][Full Text] [Related]
2. Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer.
Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
Clin Cancer Res; 2003 Nov; 9(14):5313-7. PubMed ID: 14614015
[TBL] [Abstract][Full Text] [Related]
3. Different significance between intratumoral and peritumoral lymphatic vessel density in gastric cancer: a retrospective study of 123 cases.
Wang XL; Fang JP; Tang RY; Chen XM
BMC Cancer; 2010 Jun; 10():299. PubMed ID: 20565772
[TBL] [Abstract][Full Text] [Related]
4. Peritumoral lymphangiogenesis induced by vascular endothelial growth factor C and D promotes lymph node metastasis in breast cancer patients.
Zhao YC; Ni XJ; Li Y; Dai M; Yuan ZX; Zhu YY; Luo CY
World J Surg Oncol; 2012 Aug; 10():165. PubMed ID: 22906075
[TBL] [Abstract][Full Text] [Related]
5. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
6. Tumour expression of lymphangiogenic growth factors but not lymphatic vessel density is implicated in human cervical cancer progression.
Sotiropoulou N; Bravou V; Kounelis S; Damaskou V; Papaspirou E; Papadaki H
Pathology; 2010 Dec; 42(7):629-36. PubMed ID: 21080871
[TBL] [Abstract][Full Text] [Related]
7. Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix.
Gombos Z; Xu X; Chu CS; Zhang PJ; Acs G
Clin Cancer Res; 2005 Dec; 11(23):8364-71. PubMed ID: 16322297
[TBL] [Abstract][Full Text] [Related]
8. Lymphatic vessel density, microvessel density and lymphangiogenic growth factor expression in colorectal cancer.
Duff SE; Jeziorska M; Kumar S; Haboubi N; Sherlock D; O'Dwyer ST; Jayson GC
Colorectal Dis; 2007 Nov; 9(9):793-800. PubMed ID: 17931169
[TBL] [Abstract][Full Text] [Related]
9. Clinical implications of increased lymph vessel density in the lymphatic metastasis of early-stage invasive cervical carcinoma: a clinical immunohistochemical method study.
Zhang SQ; Yu H; Zhang LL
BMC Cancer; 2009 Feb; 9():64. PubMed ID: 19232130
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factors C and D and lymphangiogenesis at the early stage of esophageal squamous cell carcinoma progression.
Kumagai Y; Tachikawa T; Higashi M; Sobajima J; Takahashi A; Amano K; Fukuchi M; Ishibashi K; Mochiki E; Yakabi K; Tamaru J; Ishida H
Dis Esophagus; 2018 Aug; 31(8):. PubMed ID: 29800478
[TBL] [Abstract][Full Text] [Related]
11. High density of peritumoral lymphatic vessels measured by D2-40/podoplanin and LYVE-1 expression in gastric cancer patients: an excellent prognostic indicator or a false friend?
Rudno-Rudzinska J; Kielan W; Grzebieniak Z; Dziegiel P; Donizy P; Mazur G; Knakiewicz M; Frejlich E; Halon A
Gastric Cancer; 2013 Oct; 16(4):513-20. PubMed ID: 23238856
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor (VEGF)-C, VEGF-D, VEGFR-3 and D2-40 expressions in primary breast cancer: Association with lymph node metastasis.
Eroğlu A; Ersöz C; Karasoy D; Sak S
Adv Clin Exp Med; 2017; 26(2):245-249. PubMed ID: 28791841
[TBL] [Abstract][Full Text] [Related]
13. Lymphatic vessel density in pulmonary adenocarcinoma immunohistochemically evaluated with anti-podoplanin or anti-D2-40 antibody is correlated with lymphatic invasion or lymph node metastases.
Adachi Y; Nakamura H; Kitamura Y; Taniguchi Y; Araki K; Shomori K; Horie Y; Kurozawa Y; Ito H; Hayashi K
Pathol Int; 2007 Apr; 57(4):171-7. PubMed ID: 17316411
[TBL] [Abstract][Full Text] [Related]
14. Expression of vascular endothelial growth factor-C and its receptor in invasive micropapillary carcinoma of the breast.
Li YS; Kaneko M; Amatya VJ; Takeshima Y; Arihiro K; Inai K
Pathol Int; 2006 May; 56(5):256-61. PubMed ID: 16669874
[TBL] [Abstract][Full Text] [Related]
15. [New markers for pharmacological targeting in bladder cancer with lymph node metastasis].
Herrmann E; Eltze E; Köpke T; Bolenz C; Bierer S; Neumann J; Hertle L; Wülfing C
Aktuelle Urol; 2007 Sep; 38(5):392-7. PubMed ID: 17907066
[TBL] [Abstract][Full Text] [Related]
16. [The expression and role of VEGF-C and its receptor FLT-4 in laryngeal and hypopharyngeal squamous cell carcinoma metastasis].
Li L; Liu Q; Dong P
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Sep; 19(18):845-9. PubMed ID: 16375119
[TBL] [Abstract][Full Text] [Related]
17. Prox 1, VEGF-C and VEGFR3 expression during cervical neoplasia progression as evidence of an early lymphangiogenic switch.
Cimpean AM; Mazuru V; Saptefrati L; Ceausu R; Raica M
Histol Histopathol; 2012 Dec; 27(12):1543-50. PubMed ID: 23059885
[TBL] [Abstract][Full Text] [Related]
18. The expression of vascular endothelial growth factor-A and -C, and receptors 1 and 3: correlation with lymph node metastasis and prognosis in tongue squamous cell carcinoma.
Tanigaki Y; Nagashima Y; Kitamura Y; Matsuda H; Mikami Y; Tsukuda M
Int J Mol Med; 2004 Sep; 14(3):389-95. PubMed ID: 15289890
[TBL] [Abstract][Full Text] [Related]
19. [Expression and clinical significance of VEGF-C and Flt-4 in tongue squamous cell carcinoma].
Li QL; Chen FJ; Zeng ZY; Yang AK; Wu QL; Zhang HZ; Hou JH
Ai Zheng; 2006 Feb; 25(2):235-40. PubMed ID: 16480594
[TBL] [Abstract][Full Text] [Related]
20. Expression of vascular endothelial growth factor (VEGF)-C and -D in gastric carcinoma.
Shida A; Fujioka S; Kobayashi K; Ishibashi Y; Nimura H; Mitsumori N; Yanaga K
Int J Clin Oncol; 2006 Feb; 11(1):38-43. PubMed ID: 16508727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
